Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Poseida Therapeutics, Inc. | President, Gene Therapy | Common Stock | 419K | $1.73M | $4.13 | Mar 1, 2024 | Direct |
Poseida Therapeutics, Inc. | President, Gene Therapy | Employee Stock Option (Right to Buy) | 112K | Mar 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PSTX | Poseida Therapeutics, Inc. | Mar 1, 2024 | 3 | -$148K | 4 | Mar 4, 2024 | President, Gene Therapy |
PSTX | Poseida Therapeutics, Inc. | Mar 1, 2023 | 3 | -$142K | 4 | Mar 2, 2023 | President, Gene Therapy |
PSTX | Poseida Therapeutics, Inc. | Mar 1, 2022 | 2 | $0 | 4 | Mar 1, 2022 | President, Gene Therapy |
PSTX | Poseida Therapeutics, Inc. | Feb 21, 2022 | 0 | $0 | 3 | Mar 1, 2022 | President, Gene Therapy |